Srinivas Murali
Advanced Heart Failure and Transplant Cardiology · Pittsburgh, PANPI 1316921877
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boehringer Ingelheim at 25.5% of the total. Reporting peaked in 2019 at $12,560 and has fallen 99.9% since, to $14 in 2024.
Across 82 payments — averaging $481.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$10K
- Pfizer$8K
- Novartis$6K
- Lilly USA, LLC$6K
- Impulse Dynamics (USA) Inc.$3K
- Medtronic$2K
- plus $5K from 16 others
Across 59 payments — averaging $2128.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$90K
- Pfizer$36K
What the payments were for
- Consulting fees$7,53619%
- Speaking & faculty fees$20,44052%
- Travel & lodging$8,78722%
- Food & beverage$2,6227%
- Education$1020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 9 | $10,050 |
| Pfizer | 5 | $7,784 |
| Novartis | 5 | $5,916 |
| Lilly USA, LLC | 6 | $5,500 |
| Impulse Dynamics (USA) Inc. | 9 | $3,166 |
| Medtronic(2 entities) | 23 | $2,214 |
| W. L. Gore & Associates, Inc. | 2 | $2,160 |
| Akcea Therapeutics, Inc. | 1 | $1,590 |
| Abbott | 2 | $258 |
| Boston Scientific | 2 | $205 |
| AstraZeneca | 2 | $136 |
| Amgen | 2 | $113 |
| Regeneron Healthcare Solutions, Inc. | 1 | $89 |
| Johnson & Johnson | 3 | $76 |
| Lexicon Pharmaceuticals, Inc. | 1 | $67 |
| Novo Nordisk | 1 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| Heartflow, Inc. | 1 | $33 |
| Sensible Medical Innovations Inc | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Bracco Diagnostics Inc. | 1 | $14 |
| United Therapeutics Corporation | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$15,550
- ENTRESTO$5,797
- OPTIMIZER SMART SYSTEM$3,000
- Product in Development$2,160
- TEGSEDI$1,590
- HeartMate 3 Left Ventricular Dev$164
- VYNDAQEL$138
- Watchman$122
How this compares
$39,488 in reported general payments places this provider in the 80th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.
See all advanced heart failure and transplant cardiology providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 12 | $12,514 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $5,500 | $12,51412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.
Other advanced heart failure and transplant cardiology in Pittsburgh
- Andrew PogozelskiPittsburgh$401K
- Sideris FacarosPittsburgh$21K
- Matthew LanderPittsburgh$16K
- Gavin HickeyPittsburgh$5K
- Amresh RainaPittsburgh$4K
- Jenna SkowronskiPittsburgh$4K
- Ravi RamaniPittsburgh$4K
- Miguel Pinilla VeraPittsburgh$4K
- Anjali VaidyaPhiladelphia$762K
- Brendan CarryDanville$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.